Atlas Trials

Preoperative Immunotherapy Combined With Stereotactic Radiation Therapy Boost in the Treatment of HER2-negative Breast Cancer

Clinical trial NCT06472583 · RECRUITING

Trial details

NCT number
NCT06472583
Sponsor
Maria Sklodowska-Curie National Research Institute of Oncology
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2024-04-11
Primary completion
2028-02-28
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.